New Year Bumper Sale @ Rs. 1 X
Acinimide is an allopathic medicine The correct dosage of Acinimide depends on the patient's age, gender, and medical history. This information has been provided in detail in the dosage section.
Acinimide is used to treat the following -
Other Benefits
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
Age Group | Dosage |
Is the use of Acinimide safe for pregnant women?
Acinimide is safe to take during pregnancy.
Is the use of Acinimide safe during breastfeeding?
Acinimide is safe for breastfeeding women.
What is the effect of Acinimide on the Kidneys?
Acinimide rarely harms the kidneys.
What is the effect of Acinimide on the Liver?
The liver can be affected by Acinimide. If you experience any unwanted effects of this drug, stop taking it and consult your doctor. You should restart Acinimide only after medical advice.
What is the effect of Acinimide on the Heart?
Very few cases of side effects of Acinimide on the heart have been reported.
Acinimide should not be taken with following medicines due to severe side effects it may cause to patients -
Life Threatening
Severe
Moderate
Mild
If you are suffering from any of the following diseases, you should not take Acinimide unless your doctor advises you to do so -
Is this Acinimide habit forming or addictive?
Acinimide is not addictive in nature.
Interaction between Food and Acinimide
Information is not available on the interaction of any foods with Acinimide, due to a lack of research on this.
Interaction between Alcohol and Acinimide
Taking Acinimide with alcohol can have severely harmful effects on your health.
This medicine data has been created by -
B.Pharma, Pharmacy
5 Years of Experience
References
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 357
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 427-429
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 204
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Voltaren® (diclofenac sodium)
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Diclofenac (diclofenac sodium)
Therapeutic Goods Administration (TGA): Department of Health [Internet]. Governmet of Australia; Package leaflet information for the user; Solaraze® (diclofenac sodium)
KD Tripathi. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 206-207
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Acetaminophen (acetaminophen)
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Ofirmev (acetaminophen)